iwAL 2018 Session I

 

What Does Genomics Tell Us About Patient Management?

In session I of iwAL 2018, Ari Melnick, MD, Torsten Haferlach, MD, and Klaus Metzeler, MD, discuss the role of genomics in managing patients with acute leukemias. The following e-learning webcasts cover topics on the epigenetic landscape in acute leukemias, the clinical implications of genetic and molecular characterization of AML, and epigenetic regulator mutations.

Presentations
Epigenetic Landscape in Acute Leukemias
Ari Melnick, MD
Weill Cornell Medicine, New York City, NY
10 February, 2018

Ari Melnick, MD, from Weill Cornell Medicine, New York City, NY, talks about the epigenetic landscape in acute leukemias.

Clinical Implications of Genetic and Molecular Characterization of AML
Torsten Haferlach, MD
MLL Munich Leukemia Laboratory, Munich, Germany
9 February, 2018

Torsten Haferlach, MD, from MLL Munich Leukemia Laboratory, Munich, Germany, discusses the clinical implications of genetic and molecular characterization of AML.

Epigenetic Regulator Mutations
Klaus Metzeler, MD
LMU-University Hospital Munich, Munich, Germany
9 February, 2018

Klaus Metzeler, MD, of LMU-University Hospital Munich, Munich, Germany, presents a talk on mutations in epigenetic regulators.